BAD and cancer: It was found that phosphorylation of Bad may promote drug resistance and survival of cancer cells whereas lack of phosphorylation modification on Bad results in a subcellular relocation of Bad to the mitochondria and triggering apoptosis by releasing cytochrome c to the cytosol [44,45,46].